Autopsy report · NCT02498444

Perioperative Treprostinil in Pediatric Patients Undergoing the Fontan Operation

“Interim futility analysis”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 5 years 3 months before it stopped.
• 34 participants enrolled.
• Results were posted on the registry 1 year 4 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Stanford University

Sponsor type

University, hospital or other

Conditions

Single Ventricle

Interventions

Treprostinil

Participants

34

Sites

1

Countries

United States

Trials that died the same way

• Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke
  “The result of a pre-planned interim futility analysis” (95% match in meaning)
• Study of M5049 in DM and PM Participants (NEPTUNIA)
  “Based on interim analyses for futility” (94% match in meaning)
• Sevoflurane and Percutaneous Coronary Intervention by Stent
  “interim analysis suggests futility” (88% match in meaning)
• Bivalirudin Infusion for Ventricular Infarction Limitation
  “Futility at the interim analysis.” (87% match in meaning)
• Interest of Intravitreal Injections of Anti-VEGF as Initial and Adjuvant Treatment in Coats Disease
  “Study futility based on the interim analysis” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.